28th Annual Perspectives in Urology: Point-Counterpoint Agenda (2019)

Thursday, November 14, 2019

10:00am –12:00pm Registration – Grande Ballroom Foyer
12:00pm – 1:00pm

Industry Lunch Symposium – Grande Ballroom A&B
Examining a Therapeutic Option for Castration-Resistant Prostate Cancer (CPRC)
Speaker William J. Aronson, MD
Supported by Astellas US Pharma and Pfizer Oncology

12:00pm – 7:30pm Exhibits Open – Grande Ballroom C
1:00pm – 1:10pm Welcome and Introduction
E. David Crawford, MD
1:10pm – 3:10pm SESSION I: GENERAL UROLOGY
Mitchell R. Humphreys, MD – Moderator
1:10pm – 1:20pm Updates in LUTS: Treating Overactive Bladder and Nocturia
Mitchell R. Humphreys, MD
1:20pm – 1:50pm Treating BPH: Comparing HoLEP, Rezum, UroLift, and Aquablation
Mitchell R. Humphreys, MD
1:50pm – 2:00pm Genomic Classification of Prostate Cancer Risk
A. Karim Kader, MD, PhD
2:00pm – 2:20pm Panel Discussion
2:20pm – 2:40pm Break and Visit Exhibits – Grande Ballroom C
2:40pm – 4:10pm SESSION II: BLADDER/UPPER TRACK CANCERS
A. Karim Kader, MD, PhD – Moderator
2:40pm – 2:50pm BCG Failure: Defining and Managing Difficult Patients
Donald L. Lamm, MD
2:50pm – 3:00pm Updating the Definitions, Endpoints, and Clinical Trial Designs
for NMIBC from the International Bladder Cancer Group
Donald L. Lamm, MD
3:00pm – 3:10pm Upper Tract Urothelial Cancer: What You Need to Know
Mitchell R. Humphreys, MD
3:10pm – 3:30pm Panel Discussion
3:30pm – 3:50pm Point Counterpoint: BCG Maintenance – Full SWOG Course
Pro: Erik P. Castle, MD
Con: A. Karim Kader, MD, PhD
3:50pm – 4:10pm Point-Counterpoint: Neoadjuvant Chemotherapy Prior to Cystectomy
Pro: E. David Crawford, MD
Con: A. Karim Kader, MD, PhD
4:10pm – 5:30pm SESSION III: PROSTATE CANCER SCREENING
E. David Crawford, MD – Moderator
4:10pm – 4:20pm The USPSTF Prostate Cancer Screening Recommendations
A. Karim Kader, MD, PhD
4:20pm – 4:40pm Is There a Path Forward for Screening for Prostate Cancer?
E. David Crawford, MD
4:40pm – 5:00pm Break and Visit Exhibits – Grande Ballroom C
5:00pm – 5:20pm Panel Discussion
5:20pm – 5:40pm Point-Counterpoint: Prostate Cancer Screening and Early Detection: Should We Follow the NCCN Guidelines?
Pro: A. Karim Kader, MD, PhD
Con: Robert E. Donohue, MD
5:40pm – 5:50pm Ten Minute Warning: Ten One-Minute Updates on Ten Topics of Most Concern to Urologists
Robert E. Donohue, MD
5:50pm – 6:30pm Welcome Reception in Exhibit Hall – Grande Ballroom C
Evening On Own

Friday, November 15, 2019

7:00am – 12:00pm Exhibits Open – Grande Ballroom C
7:00am – 8:00am Industry Breakfast Symposium – Grande Ballroom A&B
“Treating Patients with Advanced Prostate Cancer: Metastatic and Non-Metastatic PC”
Panelists: E. David Crawford, MD and Steven E. Finkelstein, MD
Supported by Janssen Biotech
8:00am – 9:40am SESSION IV: LOCALIZED PROSTATE CANCER
Moderator: David C. Beyer, MD
8:00am – 8:10am Next Generation Updates: Advances in Radiation Oncology:
Prostate Cancer
David C. Beyer, MD
8:10am – 8:20am Updates in Brachytherapy
David C. Beyer, MD
8:20am – 8:40am Panel Discussion
8:40am – 9:00am Point-Counterpoint: Is MRI Fusion Biopsy the New Gold
Standard of Diagnosis?
Pro: A. Karim Kader, MD, PhD
Con: E. David Crawford, MD
9:00am – 9:20am Point-Counterpoint: It Is Time to Abandon Transrectal Prostate
Biopsy for Perineal Prostate Biopsy
Pro: E. David Crawford, MD
Con: Erik P. Castle, MD
9:20am – 9:50am Break and Visit Exhibits – Grande Ballroom B
9:50am – 10:30am SESSION V: KIDNEY CANCER
Robert G. Uzzo, MD
9:50am – 10:00am Update on the Management of Locally Advanced RCC
Robert G. Uzzo, MD
10:00am – 10:10am Renal Mass and Localized Renal Cancer: AUA Guidelines
Robert G. Uzzo, MD
10:10am – 10:30am Panel Discussion
10:30am – 11:30am SESSION VI: CASE REPORTS AND SURGICAL VIDEOS
Erik P. Castle, MD – Moderator
Afternoon and Evening On Own

Saturday, November 16, 2019

7:00am – 10:30am Exhibits Open – Grande Ballroom C
7:00am – 8:00am Continental Breakfast – Grande Ballroom A&B
8:00am – 9:10am SESSION VII: SURGICAL APPROACHES TO UROLOGIC
DISORDERS
Manoj J. Monga, MD – Moderator
8:00am – 8:10am Adjuvant Medical Therapy Following Surgical Stone
Management
Manoj J. Monga, MD
8:10am – 8:20am PNL: Extreme Makeover for an Old Technique
Manoj J. Monga, MD
8:20am – 8:40am Panel Discussion
8:40am – 11:00am SESSION VIII: ADVANCED PROSTATE CANCER
Alan H. Bryce, MD – Moderator
8:40am – 8:50am Genetic Testing and Next Generation DNA Sequencing
Alan H. Bryce, MD
8:50am – 9:10am Point-Counterpoint: There Is A Role for Currently Available
Biomarkers/Genomics in the Risk Stratification of Prostate Cancer
Pro: E. David Crawford, MD
Con: Alan H. Bryce, MD
9:10am – 9:20am Break and Visit Exhibits
9:20am – 9:30am Next Generation Imaging for Prostate Cancer
Phillip J. Koo, MD
9:30am – 9:40am Updates in Treatment for mCRPC
Daniel P. Petrylak, MD
9:40am – 9:50am Immunotherapy Advances for CRPC
Daniel P. Petrylak, MD
9:50am – 10:00am Panel Discussion
10:00am – 10:10am Latest Developments in Radiological Interventions and
Theranostics
Phillip Koo, MD
10:10am – 10:20am The Current and Future Role of Radium 223 in Prostate Cancer
Phillip Koo, MD
10:20am – 10:30am nmCRPC: Is Navigating the M0 Space the Next Moon Shot?
E. David Crawford, MD
10:40am – 10:50am Panel Discussion
10:50am – 11:00am Closing Remarks
E. David Crawford, MD
11:00am Adjourn